At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,099 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Women's HIV SeroIncidence Study (ISIS)
In Brief
An observational study for HIV Infections. Completed, enrolled 2,099 participants across 9 sites.
Detailed Summary
Approximately 30 percent of new HIV infections in the Unites States occur in women, with a disproportionate number occurring in women of color. This observational study has been designed to help determine the HIV incidence among women in the study communities as well as to identify steps that women can take to lower their HIV-infection risk.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
First PostedOct 2009
Primary CompletionMar 2011
TodayJul 2026
First PostedOct 15, 2009
Enrollment StartApr 1, 2009
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 16.7 years ago